Test for cancer using a noninvasive sample
Part of Cancer clinical trials.
This trial studies a noninvasive test to look for signs of cancer in people newly diagnosed with certain cancers. It aims to see whether the test can help detect or identify cancer before treatment starts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have newly diagnosed breast, colorectal, non-small cell lung cancer, or anaplastic glioblastoma
- You have not started radiation, chemo, or chemoradiation yet
- You’re over 18 years old and can follow the study plan and sign consent
- You do not have another past cancer diagnosis (except certain skin cancers or in-situ cervical cancer that were well treated)
- You are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for cancer-related material in blood, urine, and sometimes bone marrow. It may help researchers understand how to detect cancer activity and track it over time using less invasive tests.
This study uses advanced DNA testing on tumor samples to help match cancer treatments more precisely. It may help researchers learn which cancer changes are driving your tumor and how they relate to treatment choices.
This trial takes a sample of your tumor during a standard procedure to grow it in a lab and test different drugs. The goal is to find which drugs might work best for people with your specific tumor DNA change.
This study looks for cancer-related cells and DNA in samples like blood, urine, and (for some) bone marrow. The goal is to see whether these tests can help detect or track solid cancers with minimal added procedures.
This study tests whether a new blood test can detect multiple types of cancer early by analyzing DNA fragments in your blood. Researchers are enrolling people recently diagnosed with cancer (before treatment starts) and people without cancer to develop and validate this detection method.
This observational study checks whether a blood test (a “cfDNA” test) can detect early signs of cancer or small amounts of cancer left after treatment. It may help doctors use a simple blood sample to improve cancer detection and follow-up.
Hear when a new Neoplasmata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.